EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
BioNTech (NASDAQ:BNTX) Given New $136.00 Price Target at Canaccord Genuity Group - Markets Daily
Pfizer Inc. (NYSE:PFE) Receives $28.28 Consensus Target Price from Analysts - Markets Daily
Canaccord Genuity Group Cuts BioNTech (NASDAQ:BNTX) Price Target to $136.00 - Stock Observer
Headlands Technologies LLC Takes Position in BioNTech SE Sponsored ADR $BNTX - Daily Political
Investors Purchase High Volume of BioNTech Put Options (NASDAQ:BNTX)
Pfizer (NYSE:PFE) Stock Price Down 1% - Here's What Happened - Markets Daily
Freestone Grove Partners LP Boosts Position in Pfizer Inc. $PFE
Van ECK Associates Corp Has $399.36 Million Stock Holdings in Pfizer Inc. $PFE - Stock Observer
Freestone Grove Partners LP Buys 254,644 Shares of Pfizer Inc. $PFE - Daily Political
BioNTech (BNTX) Ended A Phase 2 Colorectal Cancer Trial
BioNTech Kills a Cancer Trial Roche Helped Build
BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax - Update | Morningstar
BioNTech Target of Unusually Large Options Trading (NASDAQ:BNTX) - Zolmax
Stock Traders Buy Large Volume of Put Options on BioNTech (NASDAQ:BNTX)
FDA approves updated COVID vaccine for seniors and high-risk adults
BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat
BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast
Markets News, Aug. 28, 2026: Indexes Close Higher for Week; Marvell Weighs on Tech Stocks; Bond Yields Rise After Warsh Speech
Best Biotech Stocks To Research - August 28th - Daily Political
The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why
FDA approves updated Covid-19 vaccines
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech | Morningstar
BioNTech (BNTX) Rallied on Moderna's Win. Does a Competitor's Success Validate its Oncology Pipeline?
Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips
$7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, Challenges
Moderna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here's Who's Best Positioned.
Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips
BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger Fundamentals to Keep Climbing
BioNTech (BNTX) Is Up 25.2% After First-in-Class Pumitamig Plus B7H3 ADC Lung Data - What's Changed
BioNTech (BNTX) Stock Looks Fully Priced As It Rebounds From A 67% Fall
BioNTech (BNTX) Presents New Lung Cancer Data, Is The Stock Already Fully Valued?
Moderna Rallies 8%, BioNTech Climbs 4% as the mRNA Trade Whipsaws for a Third Session
BioNTech (NASDAQ:BNTX) Shares Up 7.4% - Here's What Happened - Daily Political
Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips
Flossbach Von Storch SE Makes New Investment in BioNTech SE Sponsored ADR $BNTX
BioNTech Sees Unusually High Options Volume (NASDAQ:BNTX)
BioNTech (NASDAQ:BNTX) Shares Gap Up - Here's Why
Moderna Rockets 93%, Merck Jumps 7% as Melanoma Therapy Meets Primary Goal in Phase 3 Trial
Biotech Stocks To Keep An Eye On - August 19th - Daily Political
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Brokerages
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives $127.81 Average Target Price from Analysts - Daily Political
BioNTech's oncology pivot comes with a new CEO
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Average Recommendation of "Moderate Buy" by Brokerages
BioNTech Just Named a New CEO. Here's What Guido Oelkers' Appointment Means for the Stock.
Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Bios Life leaves stealth with $25M and a Tempus alliance for cancer surveillance
Bank of America Corp DE Raises Stake in BioNTech SE Sponsored ADR $BNTX
Wall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to Sell - Stock Observer
Assenagon Asset Management S.A. Makes New $39.38 Million Investment in BioNTech SE Sponsored ADR $BNTX
Citigroup Cuts BioNTech (NASDAQ:BNTX) Price Target to $125.00
Bank of New York Mellon Corp Trims Stock Position in BioNTech SE Sponsored ADR $BNTX
BioNTech (NASDAQ:BNTX) Rating Lowered to Sell at Wall Street Zen
BioNTech SE Q2 Loss Rises
BioNTech deep in the red as demand for vaccines falls
BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development | Morningstar
BioNTech Q2 Earnings Call Highlights
BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market
BioNTech Cuts 2026 Sales Forecast Amid Declining COVID Vaccine Demand, ETPharma
BioNTech lowers 2026 sales outlook as COVID vaccine demand softens
BioNTech taps Sobi executive Oelkers as its next CEO
BioNTech says Sobi's Oelkers will replace Sahin as CEO - AOL
BioNTech News
US Dollar Price Forecast 2026–2030: Can Fed Rate-Hike Bets Push DXY Above 100?
GBP/USD Forecast 2026–2030: Can Sterling Hold 1.35 as Fed–BoE Rate Bets Diverge?
Bitcoin Price Prediction 2026, 2027, 2030 & 2040: How High Can BTC Go?
USD/JPY Forecast 2026–2030: Will Another Move Above 160 Trigger Fresh Yen Intervention?
Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?
Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?
Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far
Latest news
Show more
Gold Price Today, September 1: Gold Holds Near $4,454 as Fed Rate-Hike Bets Limit Rebound
SanDisk Stock Jumps 5.5% as MSCI Inclusion and Mizuho Outlook Defy Market Sell-Off
Oil Price Today: Brent Holds Above $90 as Prolonged Iran Conflict Threatens Supply
Silver Price Today, September 1: Silver Holds Near $66.64 as Fed Rate-Hike Bets Limit Recovery
Shein IPO News Today: Shares Fall 10% in Hong Kong Debut as Valuation Slips Below $25 Billion
Broadcom Earnings Preview: Can AI Chip Growth Send AVGO Stock to Another Record?
